Warfarin

Athrombin, Coumadin, Panwarfin (warfarin) is a small molecule pharmaceutical. Warfarin was first approved as Athrombin on 1982-01-01. It is used to treat atrial fibrillation, postoperative complications, pulmonary embolism, stroke, and thromboembolism amongst others in the USA. The pharmaceutical is active against vitamin K epoxide reductase complex subunit 1. In addition, it is known to target Uncharacterized protein.